Fibulin-5 expression is decreased in women with anterior vaginal wall prolapse

Int Urogynecol J Pelvic Floor Dysfunct. 2009 Feb;20(2):207-11. doi: 10.1007/s00192-008-0757-x. Epub 2008 Nov 7.

Abstract

The aim of this study was to compare fibulin-5 expression in women with and without anterior vaginal wall prolapse. Vaginal tissues were sampled in a standardized fashion from women with (n = 12) or without (n = 10) anterior vaginal wall prolapse. Quantitative real-time polymerase chain reaction was performed to measure mRNA levels of fibulin-5 (FIB-5). FIB-5 protein expression was assessed by immunohistochemistry. There were no significant differences in demographic data between the two groups. FIB-5 mRNA expression was significantly decreased in women with anterior vaginal wall prolapse compared to women without prolapse [(FIB-5 mean +/- SD mRNA expression in relative units) 0.01 +/- 0.01 vs. 0.09 +/- 0.14, P = 0.04]. Fibulin-5 staining intensity was diminished in women with prolapse compared to women without prolapse [intensity score, median (range), 1 (1-2) vs. 3 (2-3), P = 0.04]. Fibulin-5 expression is decreased in vaginal biopsies from women with prolapse. Changes in fibulin expression may play a role in the development of pelvic organ prolapse.

MeSH terms

  • Biopsy
  • Case-Control Studies
  • Extracellular Matrix Proteins / metabolism*
  • Female
  • Humans
  • Hysterectomy
  • Middle Aged
  • RNA, Messenger / metabolism
  • Uterine Prolapse / etiology
  • Uterine Prolapse / metabolism*
  • Uterine Prolapse / physiopathology
  • Vagina / metabolism*
  • Vagina / pathology

Substances

  • Extracellular Matrix Proteins
  • FBLN5 protein, human
  • RNA, Messenger